HEADER TRANSFERASE/TRANSFERASE INHIBITOR 19-NOV-12 4I0R TITLE CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(3,4,5- TITLE 2 TRIMETHOXY-PHENYL)-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID TITLE 3 ISOPROPYLAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN (UNP RESIDUES 356-635); COMPND 5 SYNONYM: SPLEEN TYROSINE KINASE, P72-SYK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.KUGLSTATTER,A.G.VILLASENOR REVDAT 3 20-SEP-23 4I0R 1 REMARK SEQADV REVDAT 2 17-JUL-19 4I0R 1 REMARK REVDAT 1 30-OCT-13 4I0R 0 JRNL AUTH F.PADILLA,N.BHAGIRATH,S.CHEN,E.CHIAO,D.M.GOLDSTEIN, JRNL AUTH 2 J.C.HERMANN,J.HSU,J.J.KENNEDY-SMITH,A.KUGLSTATTER,C.LIAO, JRNL AUTH 3 W.LIU,L.E.LOWRIE,K.C.LUK,S.M.LYNCH,J.MENKE,L.NIU,T.D.OWENS, JRNL AUTH 4 C.O-YANG,A.RAILKAR,R.C.SCHOENFELD,M.SLADE,S.STEINER,Y.C.TAN, JRNL AUTH 5 A.G.VILLASENOR,C.WANG,J.WANNER,W.XIE,D.XU,X.ZHANG,M.ZHOU, JRNL AUTH 6 M.C.LUCAS JRNL TITL PYRROLOPYRAZINES AS SELECTIVE SPLEEN TYROSINE KINASE JRNL TITL 2 INHIBITORS. JRNL REF J.MED.CHEM. V. 56 1677 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23350847 JRNL DOI 10.1021/JM301720P REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 17258 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 931 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1060 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.3090 REMARK 3 BIN FREE R VALUE SET COUNT : 48 REMARK 3 BIN FREE R VALUE : 0.3390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2152 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 80 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : -2.71000 REMARK 3 B33 (A**2) : 2.70000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.266 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.212 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.174 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.526 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2235 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3012 ; 1.101 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 259 ; 4.990 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 103 ;37.782 ;24.078 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 408 ;14.239 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;16.477 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 312 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1686 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1053 ; 0.180 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1511 ; 0.301 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 104 ; 0.127 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 35 ; 0.137 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.097 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1367 ; 0.565 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2104 ; 0.926 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1046 ; 1.331 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 908 ; 2.048 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 363 A 639 REMARK 3 ORIGIN FOR THE GROUP (A): 3.6405 10.7144 20.2481 REMARK 3 T TENSOR REMARK 3 T11: -0.0062 T22: 0.0395 REMARK 3 T33: -0.0352 T12: -0.0274 REMARK 3 T13: 0.0160 T23: 0.0051 REMARK 3 L TENSOR REMARK 3 L11: 2.0366 L22: 4.2599 REMARK 3 L33: 1.1822 L12: 1.2694 REMARK 3 L13: -1.4589 L23: -1.5990 REMARK 3 S TENSOR REMARK 3 S11: -0.1687 S12: -0.0014 S13: -0.0243 REMARK 3 S21: -0.1234 S22: 0.0575 S23: -0.2558 REMARK 3 S31: 0.1402 S32: -0.0900 S33: 0.1112 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4I0R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-NOV-12. REMARK 100 THE DEPOSITION ID IS D_1000076159. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18234 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 45.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05500 REMARK 200 FOR THE DATA SET : 17.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.51300 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1XBB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28% PEG4000, 0.2 M AMMONIUM SULFATE, REMARK 280 0.1 M HEPES, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.89250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.07900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.55900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.07900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.89250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.55900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 353 REMARK 465 ALA A 354 REMARK 465 LEU A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 ILE A 358 REMARK 465 ARG A 359 REMARK 465 PRO A 360 REMARK 465 LYS A 361 REMARK 465 GLU A 362 REMARK 465 LYS A 375 REMARK 465 GLY A 380 REMARK 465 ASN A 381 REMARK 465 PHE A 382 REMARK 465 ASN A 406 REMARK 465 GLU A 407 REMARK 465 ALA A 408 REMARK 465 ASN A 409 REMARK 465 ASP A 410 REMARK 465 GLN A 529 REMARK 465 THR A 530 REMARK 465 HIS A 531 REMARK 465 GLY A 532 REMARK 465 HIS A 640 REMARK 465 HIS A 641 REMARK 465 HIS A 642 REMARK 465 HIS A 643 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 369 CB - CG - CD2 ANGL. DEV. = -10.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 394 -37.33 -153.19 REMARK 500 ALA A 441 -115.61 -141.47 REMARK 500 ASP A 494 36.92 -144.46 REMARK 500 ASP A 512 76.03 66.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1B4 A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4I0S RELATED DB: PDB REMARK 900 RELATED ID: 4I0T RELATED DB: PDB DBREF 4I0R A 356 635 UNP P43405 KSYK_HUMAN 356 635 SEQADV 4I0R MET A 353 UNP P43405 EXPRESSION TAG SEQADV 4I0R ALA A 354 UNP P43405 EXPRESSION TAG SEQADV 4I0R LEU A 355 UNP P43405 EXPRESSION TAG SEQADV 4I0R GLU A 636 UNP P43405 EXPRESSION TAG SEQADV 4I0R GLY A 637 UNP P43405 EXPRESSION TAG SEQADV 4I0R HIS A 638 UNP P43405 EXPRESSION TAG SEQADV 4I0R HIS A 639 UNP P43405 EXPRESSION TAG SEQADV 4I0R HIS A 640 UNP P43405 EXPRESSION TAG SEQADV 4I0R HIS A 641 UNP P43405 EXPRESSION TAG SEQADV 4I0R HIS A 642 UNP P43405 EXPRESSION TAG SEQADV 4I0R HIS A 643 UNP P43405 EXPRESSION TAG SEQRES 1 A 291 MET ALA LEU GLU GLU ILE ARG PRO LYS GLU VAL TYR LEU SEQRES 2 A 291 ASP ARG LYS LEU LEU THR LEU GLU ASP LYS GLU LEU GLY SEQRES 3 A 291 SER GLY ASN PHE GLY THR VAL LYS LYS GLY TYR TYR GLN SEQRES 4 A 291 MET LYS LYS VAL VAL LYS THR VAL ALA VAL LYS ILE LEU SEQRES 5 A 291 LYS ASN GLU ALA ASN ASP PRO ALA LEU LYS ASP GLU LEU SEQRES 6 A 291 LEU ALA GLU ALA ASN VAL MET GLN GLN LEU ASP ASN PRO SEQRES 7 A 291 TYR ILE VAL ARG MET ILE GLY ILE CYS GLU ALA GLU SER SEQRES 8 A 291 TRP MET LEU VAL MET GLU MET ALA GLU LEU GLY PRO LEU SEQRES 9 A 291 ASN LYS TYR LEU GLN GLN ASN ARG HIS VAL LYS ASP LYS SEQRES 10 A 291 ASN ILE ILE GLU LEU VAL HIS GLN VAL SER MET GLY MET SEQRES 11 A 291 LYS TYR LEU GLU GLU SER ASN PHE VAL HIS ARG ASP LEU SEQRES 12 A 291 ALA ALA ARG ASN VAL LEU LEU VAL THR GLN HIS TYR ALA SEQRES 13 A 291 LYS ILE SER ASP PHE GLY LEU SER LYS ALA LEU ARG ALA SEQRES 14 A 291 ASP GLU ASN TYR TYR LYS ALA GLN THR HIS GLY LYS TRP SEQRES 15 A 291 PRO VAL LYS TRP TYR ALA PRO GLU CYS ILE ASN TYR TYR SEQRES 16 A 291 LYS PHE SER SER LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 291 LEU MET TRP GLU ALA PHE SER TYR GLY GLN LYS PRO TYR SEQRES 18 A 291 ARG GLY MET LYS GLY SER GLU VAL THR ALA MET LEU GLU SEQRES 19 A 291 LYS GLY GLU ARG MET GLY CYS PRO ALA GLY CYS PRO ARG SEQRES 20 A 291 GLU MET TYR ASP LEU MET ASN LEU CYS TRP THR TYR ASP SEQRES 21 A 291 VAL GLU ASN ARG PRO GLY PHE ALA ALA VAL GLU LEU ARG SEQRES 22 A 291 LEU ARG ASN TYR TYR TYR ASP VAL VAL ASN GLU GLY HIS SEQRES 23 A 291 HIS HIS HIS HIS HIS HET 1B4 A 701 27 HETNAM 1B4 N-(PROPAN-2-YL)-2-(3,4,5-TRIMETHOXYPHENYL)-5H- HETNAM 2 1B4 PYRROLO[2,3-B]PYRAZINE-7-CARBOXAMIDE FORMUL 2 1B4 C19 H22 N4 O4 FORMUL 3 HOH *80(H2 O) HELIX 1 1 ASP A 366 LYS A 368 5 3 HELIX 2 2 ALA A 412 GLN A 426 1 15 HELIX 3 3 LEU A 456 ASN A 463 1 8 HELIX 4 4 LYS A 467 SER A 488 1 22 HELIX 5 5 ALA A 496 ARG A 498 5 3 HELIX 6 6 PRO A 535 TYR A 539 5 5 HELIX 7 7 ALA A 540 TYR A 547 1 8 HELIX 8 8 SER A 550 SER A 567 1 18 HELIX 9 9 LYS A 577 LYS A 587 1 11 HELIX 10 10 PRO A 598 TRP A 609 1 12 HELIX 11 11 GLY A 618 GLY A 637 1 20 SHEET 1 A 5 LEU A 370 LEU A 372 0 SHEET 2 A 5 THR A 384 GLN A 391 -1 O TYR A 389 N THR A 371 SHEET 3 A 5 VAL A 396 ILE A 403 -1 O ILE A 403 N THR A 384 SHEET 4 A 5 TRP A 444 GLU A 449 -1 O LEU A 446 N LYS A 402 SHEET 5 A 5 MET A 435 GLU A 440 -1 N CYS A 439 O MET A 445 SHEET 1 B 3 GLY A 454 PRO A 455 0 SHEET 2 B 3 VAL A 500 THR A 504 -1 O LEU A 502 N GLY A 454 SHEET 3 B 3 TYR A 507 ILE A 510 -1 O LYS A 509 N LEU A 501 SHEET 1 C 2 PHE A 490 VAL A 491 0 SHEET 2 C 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 D 2 TYR A 526 LYS A 527 0 SHEET 2 D 2 LYS A 548 PHE A 549 -1 O PHE A 549 N TYR A 526 SITE 1 AC1 13 LEU A 377 ALA A 400 MET A 448 GLU A 449 SITE 2 AC1 13 ALA A 451 GLU A 452 GLY A 454 PRO A 455 SITE 3 AC1 13 ASN A 499 LEU A 501 SER A 511 HOH A1001 SITE 4 AC1 13 HOH A1062 CRYST1 39.785 85.118 90.158 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025135 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011748 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011092 0.00000